17-44354082-G-A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_198475.3(FAM171A2):​c.2132C>T​(p.Pro711Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000271 in 1,106,416 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000010 ( 0 hom. )

Consequence

FAM171A2
NM_198475.3 missense

Scores

1
1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.74

Publications

0 publications found
Variant links:
Genes affected
FAM171A2 (HGNC:30480): (family with sequence similarity 171 member A2) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.10857651).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FAM171A2NM_198475.3 linkc.2132C>T p.Pro711Leu missense_variant Exon 8 of 8 ENST00000293443.12 NP_940877.2 A8MVW0
FAM171A2XM_017024490.2 linkc.1580C>T p.Pro527Leu missense_variant Exon 6 of 6 XP_016879979.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FAM171A2ENST00000293443.12 linkc.2132C>T p.Pro711Leu missense_variant Exon 8 of 8 1 NM_198475.3 ENSP00000293443.6 A8MVW0

Frequencies

GnomAD3 genomes
AF:
0.000137
AC:
20
AN:
146348
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000491
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000104
AC:
10
AN:
960068
Hom.:
0
Cov.:
29
AF XY:
0.00000887
AC XY:
4
AN XY:
451096
show subpopulations
African (AFR)
AF:
0.000483
AC:
9
AN:
18630
American (AMR)
AF:
0.00
AC:
0
AN:
4648
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
9156
East Asian (EAS)
AF:
0.00
AC:
0
AN:
15304
South Asian (SAS)
AF:
0.00
AC:
0
AN:
18472
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
14106
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2268
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
842536
Other (OTH)
AF:
0.0000286
AC:
1
AN:
34948
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.545
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000137
AC:
20
AN:
146348
Hom.:
0
Cov.:
31
AF XY:
0.0000983
AC XY:
7
AN XY:
71212
show subpopulations
African (AFR)
AF:
0.000491
AC:
20
AN:
40746
American (AMR)
AF:
0.00
AC:
0
AN:
14778
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3390
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5016
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4800
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8476
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
310
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
65910
Other (OTH)
AF:
0.00
AC:
0
AN:
2012
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000142
Hom.:
0
Bravo
AF:
0.000110

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 31, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2132C>T (p.P711L) alteration is located in exon 8 (coding exon 8) of the FAM171A2 gene. This alteration results from a C to T substitution at nucleotide position 2132, causing the proline (P) at amino acid position 711 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
17
DANN
Benign
0.96
DEOGEN2
Benign
0.0023
T
Eigen
Benign
-0.99
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.46
T
M_CAP
Uncertain
0.086
D
MetaRNN
Benign
0.11
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N
PhyloP100
1.7
PrimateAI
Pathogenic
0.86
D
PROVEAN
Benign
-0.15
N
REVEL
Benign
0.012
Sift
Benign
0.27
T
Sift4G
Benign
0.40
T
Polyphen
0.43
B
Vest4
0.24
MutPred
0.37
Loss of glycosylation at P711 (P = 0.0215);
MVP
0.095
ClinPred
0.27
T
GERP RS
0.048
Varity_R
0.045
gMVP
0.21
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs960745701; hg19: chr17-42431450; API